These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18041124)

  • 41. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
    Eltahawy AT
    J Chemother; 1997 Dec; 9(6):403-10. PubMed ID: 9491839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
    Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002.
    Mendes C; Oplustil C; Sakagami E; Turner P; Kiffer C;
    Braz J Infect Dis; 2005 Feb; 9(1):44-51. PubMed ID: 15947846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance surveillance in Italy: four-year results from the MYSTIC program.
    Fontana R; Lo Cascio G; Giacobone E; Romero E; Cipriani P; Sessa R; Franchino L
    J Chemother; 2002 Aug; 14(4):323-31. PubMed ID: 12420847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
    Patzer JA; Dzierzanowska D; Turner PJ
    J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of the sensitivity to meropenem of some bacterial strains with nosocomial potential].
    Dan L; Licker M; Grecu D; Dumitraşcu V; Branea D; Berceanu-Văduva D; Crăciunescu M; Iancu A; Orb C; Holoşpin M; Hogea E; Muntean D; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):107-12. PubMed ID: 15341323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Review of the effectiveness of an empirical antibiotic therapy in suspected ventilator-associated pneumonia].
    Kozioł-Montewka M; Jaworska-Gromaszek I; Biernacka J; Pluta A; Niedźwiadek J; Kaczor D; Ligięza J; Rudzki S
    Anestezjol Intens Ter; 2011; 43(3):163-8. PubMed ID: 22011920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates.
    Sarubbi F; Franzus B; Verghese A
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):65-8. PubMed ID: 1563388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
    Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran.
    Hadadi A; Rasoulinejad M; Maleki Z; Yonesian M; Shirani A; Kourorian Z
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):301-5. PubMed ID: 18036759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Sidorenko SV; Rezvan SP; Grudinina SA; Sterkhova GV; Aleksandrova IA
    Antibiot Khimioter; 1998; 43(1):4-14. PubMed ID: 9532326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014.
    Pleşca CE; Luca MC; Luca AS; Constantinescu S; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1141-6. PubMed ID: 26793861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic susceptibility of isolates from paediatric intensive care units in Zagreb.
    Bedenić B; Prahin E; Vranić-Ladavac M; Atalić V; Sviben M; Frančula-Zaninović S; Plečko V; Kalenić S
    Med Glas (Zenica); 2014 Feb; 11(1):72-9. PubMed ID: 24496344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbapenem resistance in Acinetobacter baumannii: where is it heading?
    Deveci Ö; Dal T; Tekin R; Bozkurt F; Tekin A; Dayan S
    Infez Med; 2013 Sep; 21(3):211-5. PubMed ID: 24008854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
    Sawicka-Grzelak A; Rokosz A
    Med Dosw Mikrobiol; 1998; 50(1-2):69-76. PubMed ID: 9857616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
    Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
    Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.